Pfizer appeals denial of $75 million claim in SEC case against Cohen hedge fund
Portfolio Pulse from
Pfizer is appealing a federal judge's decision denying them $75.2 million from an insider trading settlement related to Steven A. Cohen's former hedge fund, SAC Capital Management.
January 14, 2025 | 11:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Pfizer is appealing a decision that denied them $75.2 million from an insider trading settlement involving SAC Capital Management.
The appeal by Pfizer could have financial implications if successful, potentially impacting their financials positively. However, the outcome is uncertain, and the immediate impact on stock price is neutral until further developments.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 80